Therapeutic drug monitoring: Difference between revisions

From greek.doctor
(Created page with "{{:Stub}} = measurement of drug concentration or activity in plasma * Methods ** High performance liquid chromatography ** Immunoassay * Indications ** Non-linear kinetics of drug ** When there is poor compliance ** If the therapeutic effect can’t be assessed clinically ** If the therapeutic index is low *** Warfarin *** Aminoglycosides *** Antipsychotics *** Digoxin *** Lithium ** When there are signs of overdose ** To determine pharmacokinetic interactions Categ...")
 
No edit summary
 
Line 1: Line 1:
{{:Stub}}
{{:Stub}}
 
<section begin="clinical biochemistry" />
= measurement of drug concentration or activity in plasma
= measurement of drug concentration or activity in plasma


Line 18: Line 18:
** When there are signs of overdose
** When there are signs of overdose
** To determine pharmacokinetic interactions
** To determine pharmacokinetic interactions
 
<section end="clinical biochemistry" />
[[Category:Laboratory Medicine]]
[[Category:Laboratory Medicine]]

Latest revision as of 11:07, 18 June 2024

This article is a stub, meaning that it is unfinished. It will eventually be expanded.

= measurement of drug concentration or activity in plasma

  • Methods
    • High performance liquid chromatography
    • Immunoassay
  • Indications
    • Non-linear kinetics of drug
    • When there is poor compliance
    • If the therapeutic effect can’t be assessed clinically
    • If the therapeutic index is low
      • Warfarin
      • Aminoglycosides
      • Antipsychotics
      • Digoxin
      • Lithium
    • When there are signs of overdose
    • To determine pharmacokinetic interactions